Hemostasis Today

May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Raghavendra Rao: Short-Term Outcomes of Combined EVLA and Foam Sclerotherapy
May 24, 2026, 03:33

Raghavendra Rao: Short-Term Outcomes of Combined EVLA and Foam Sclerotherapy

Raghavendra Rao, General Surgeon at Vein Clinic, Founder of Best Surgical Education, LLC, shared a post on LinkedIn about a recent article by Maciej Wołkowski et al, published in JVS-VL, adding:

“Concomitant foam sclerotherapy of tributaries after truncal ablation with EVLA results in better varicose vein regression at 3 months in the short term and may result in a better quality of life at 6 months.

This comes at the cost of using too much or too concentrated sclerosant, resulting in foam sclerotherapy complications.

Non-randomized study published recently in JVS-VL.

The controversy continues regarding the need for tributary management after EVLA of the truncal veins, but a good percentage seem to need further treatments.

EVLA does have a substantial effect on tributary varicose veins.”

Title: Clinical trial of concomitant versus staged foam sclerotherapy of varicose veins following axial thermal ablation.

Authors: Maciej Wołkowski, Tomasz Urbanek, Krzysztof Wołkowski, Grzegorz Biolik, Wacław Kuczmik

Raghavendra Rao: Short-Term Outcomes of Combined EVLA and Foam Sclerotherapy

Stay updated on all scientific advances with Hemostasis Today.